Maria Á. Sánchez-Quiroga, Iván D. Benítez, Babak Mokhlesi, F.J. Gomez De Terreros, Alejandra Roncero, Carlos Ruíz-Martínez, Mariola Bretón, Maria F Troncoso, J Villanueva Herrero, Soledad López-Martín, Daniel López-Padilla, Mónica González, Teresa DIAZ DE TERAN, Candela Caballero-Eraso, Sergi Martí, Patricia Peñacoba, Marina Galdeano, Jesús Muñoz-Méndez, Javier Barca, Ferran Barbe, Isabel Utrabo, Jose A Duran, Juan F Masa, Spanish Sleep Network, Eusebi Chiner, Celia De-Dios, Jorge Lázaro, Maria Torres, Paula Rodríguez-Rodríguez, Cristina Esteban, Laura Núñez, Jose R Teran, María Isabel Asensio-Cruz, Júlia Sampol, Mercedes Pallero, Ana Hernandez-Voth, Trinidad Díaz-Cambriles, Eva Arias, Javier Sayas
RATIONALE: Obesity hypoventilation syndrome (OHS) is treated with noninvasive ventilation (NIV) that is titrated during polysomnography. Auto-adjusted NIV could obviate the need for polysomnographic titration, thereby reducing costs and delays in care. However, non-inferiority long-term clinical trials comparing auto-adjusted NIV with manually-adjusted NIV are lacking. OBJECTIVES: To determine the comparative effectiveness of automatic vs manual NIV modality in OHS. METHODS: In this multicenter, blinded, parallel group, non-inferiority and cost-effectiveness trial, we randomly assigned treatment-naïve ambulatory patients with OHS to auto-adjusted NIV (volume-targeted pressure support with auto-expiratory positive airway pressure) or manually-adjusted NIV (bilevel Positive Airway Pressure Spontaneous Timed mode (PAP ST). MEASUREMENTS: The primary outcome was change in daytime PaCO2 at 12 months, with the non-inferiority premise set at -2 mm Hg. Secondary outcomes included symptoms, quality of life, and healthcare resource utilization. Intention-to-treat and per-protocol analyses were performed. MAIN RESULTS: 205 ambulatory patients with OHS were randomized, 107 to auto-adjusted NIV and 89 to manually-adjusted NIV. The mean [95% CI] improvement in PaCO2 was -9.2 [-9.7; -8.7] mm Hg in the auto-adjusted group and -8.7 [-9.1; -8.3] mm Hg in the manually-adjusted group, with mean adjusted difference of 0.15 mm Hg between groups ([low confidence limit -1.4]; non-inferiority P = .01). Cost-effectiveness was favorable to auto-adjusted group with a saving of 1528 € (95% CI, -2 370; -6 854) per patient. There were no significant differences in other secondary outcomes. CONCLUSIONS: In ambulatory patients with OHS, auto-adjusted NIV had a non-inferior long-term effectiveness compared to manually-adjusted NIV while being more cost-effective. Auto-adjusted NIV may be preferred in clinical practice given its lower complexity and cost. CLINICALTRIAL.GOV IDENTIFIER: NCT04327336.